to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Some of my entrepreneurially-interested coworkers at the Kauffman Foundation have an interesting article on Huffington Post right now. It dissects the organic growth of 1 Million Cups (1MC) in support of a new finding: that word of mouth networking helps build early-stage startup communities better than social media.
LUMOback is the first product by LUMO, a Palo Alto-based company founded by three entrepreneurs – including one who suffered back problems for years. Charles Wang, co-founder and CMO, shared what he’s learned since the company’s launch in 2011 and the product’s release last year.
Read about the six lifescience and healthcare entrepreneurs we'll be following this week on twitter.
As a life science entrepreneur, you surely have ideas on how changing legal rules and policies could promote innovation and accelerate U.S. economic growth. The Kauffman Foundation, seeking suggestions on how to jumpstart the struggling economy, convened America’s leading legal scholars and social scientists to offer their thoughts.
Rio de Janeiro, Brazil was the host city to the 2013 Global Entrepreneurship Congress. Over 1,000 people from 144 countries shared a hot and humid week fueled by the overwhelming passion to promote entrepreneurship globally.
The vision at Bioarray Therapeutics, a biotechnology company in Boston, is to improve cancer detection and treatment. By finding genes associated with cancer, the company is developing a diagnostic for breast cancer that can help doctors and patients choose the best treatment.
With U.S. healthcare costs rising about 2.5 percent faster than inflation, there’s an urgent need to improve productivity and quality in American healthcare. A Kauffman Foundation report found that open access to medical data could help find that cost-benefit balance.
Bringing a healthcare drug or device to market requires an intense amount of capital. Federal regulation in the United States, Europe and beyond requires clinical testing and trials, as well as large sales staffs and other expenses. The early requirements for investing can force entrepreneurs to seek private, dilutive investing and rapidly cut into the amount of ownership of the company by the entrepreneur.
As a biomedical informatics researcher and biotechnology entrepreneur in the Silicon Valley, Atul Butte has big ideas for the future of life science entrepreneurship. His Butte Lab works to solve genomic medicine problems through new developments in translational bioinformatics.
When I say the phrase “workforce development” chances are a certain image is conjured in your mind. Maybe you think of tradesmen positions, like carpenters, electricians, plumbers and masons. Maybe you think vocational training programs offered by community colleges. Regardless of what your mind has been trained to conclude based on that phrase, workforce development has never been more important than it is today. But it’s not enough—on its own or simply as it is.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.